ARCHIVES

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

This article is from The Cancer Letter archive.

Vol. 24 No. 48 | December 18, 1998

Download PDF Visit The Full Archive

Related Articles

Triple-Negative Breast Cancer Equally Aggressive in Whites

February 25, 2011

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

Letter: Cancer Centers Need Ingenuity To Continue Clinical Research

October 27, 1995

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

December 30, 2011

In Brief: NBCC Honors D’Amato, Leahy, Mack, Stevens; Center Development Officers Elect Leaders

May 8, 1998

Evidence Supports Screening Younger Women, Expert Says

September 24, 1993